Previously we have 'bridged the gap between evidence and use' and 'mobilised data to accelerate evidence-generation'; we have learned from colleagues across the globe, and from consumers and policy makers.

As MI-CRE enters its fourth year it's time to...

Bring it home...

The Annual Symposium for 2024 is a two-day event and features an exciting program of presentations and panel discussions from MI-CRE researchers, including two themed sessions showcasing consumer involvement and research impact.

As always, there will be plenty of opportunity to network with friends and colleagues from across the MI-CRE nodes and our external stakeholders.

Download the Draft Program here.

We have two wonderful keynote speakers bringing it home and sharing their wisdom to grow our future in pharmacoepidemiology:

Prof Andrew Wilson, Chair of the Pharmaceutical Benefits Advisory Committee (2015-2024) and MI-CRE Chief Investigator, who will be reflecting on 9 years as Chair of the PBAC and the role of pharmacoepidemiology in PBAC decision-making.
Dr Andrea Schaffer, Epidemiologist, University of Oxford and UNSW alumna, who will be bringing home some of her insights about working in pharmacoepidemiology in Australia and abroad.

You can register for either or both days of this face-to-face event - please ensure you select the correct ticket when you checkout. This is a free event for members of MI-CRE, consumers, our policy and translational partners, as well as anyone with an interest in mobilising data to accelerate real-world evidence generation!

MI-CRE 2024 Annual Symposium and Policy Forum